Metabolic Syndrome Tied to Poor SFA Intervention Outcomes
February 16, 2011|Hospitalist News (Archived)
Author and Disclosure Information
Major Finding: Although 30-day mortality was equivalent, a significantly lower percentage of the metabolic syndrome group, 67% vs. 73%, experienced freedom from recurrent symptoms over 5 years, and they also showed a significantly lower patency.
Data Source: Retrospective database study of 870 patients who underwent endovascular treatment for symptomatic superficial femoral artery disease.
Disclosures: Dr. Smolock said that he had no relevant disclosures.
FROM THE ANNUAL MEETING OF THE SOUTHERN ASSOCIATION FOR VASCULAR SURGERY
Dr. Smolock said that he had no relevant disclosures.
